Neurotransmitter-specific polygenic scores dissect clinical heterogeneity in schizophrenia
It is suggested that NT pathway-specific polygenic profiling may capture clinically relevant variation overlooked by genome-wide approaches in SCZ by identifying genetic profiles associated with symptom severity, disease onset, and longitudinal outcomes.